Correction

Published on 04 Jun 2024

Corrigendum: Effectiveness of perindopril/amlodipine fixed-dose combination in the treatment of hypertension: a systematic review

in Drugs Outcomes Research and Policies

Truong Van Dat
Vo Linh Tu
Le Nguyen Anh Thu
Nguyen Nhat Anh Quang
Van Binh
Nguyen Thi Quynh Nga
Duong Hoang Loc
Tran Thi Hong Nguyen
Dao Ngoc Hien Tam
Hong-Han Huynh

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1426608

991 views

Original Research

Published on 04 Jun 2024

The impact of Chinese volume-based procurement on pharmaceutical market concentration

in Drugs Outcomes Research and Policies

Ying Yang
Yuxin Liu
Zongfu Mao
Jing Mao
Yalei Jin

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1386533

2,671 views
1 citation

Original Research

Published on 03 Jun 2024

Adverse events in different administration routes of semaglutide: a pharmacovigilance study based on the FDA adverse event reporting system

in Drugs Outcomes Research and Policies

Kaibin Niu
Maoxia Fan
Wulin Gao
Chen Chen
Guohua Dai

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1414268

3,095 views
1 citation

Original Research

Published on 03 Jun 2024

Analysis and discussion on the pharmaceutical centralized procurement implementation — a case study of a large provincial hospital in China

in Drugs Outcomes Research and Policies

Jingjing Cao
Yuan Ren
Chenglong Zhao
Li Wang
Fengqin Fang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1379595

861 views

Review

Published on 30 May 2024

Osteogenic mechanism of chlorogenic acid and its application in clinical practice

in Drugs Outcomes Research and Policies

Jiayu Shen
Shichen Zhang
Jiayu Zhang
Xin Wei
Zilin Wang
Bing Han

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1396354

1,443 views
1 citation

Original Research

Published on 30 May 2024

Pharmaceutical interventions for drug-related problems in the neonatal intensive care unit: incidence, types, and acceptability

in Drugs Outcomes Research and Policies

Norhan Attia Ahmed
Ehab Ahmed Fouad
Osama M. El-Asheer
A. S. M. Ghanem

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1391657

1,917 views
1 citation

Systematic Review

Published on 28 May 2024

Effect of sacubitril–valsartan on left ventricular remodeling in patients with acute myocardial infarction after primary percutaneous coronary intervention: a systematic review and meta-analysis

in Drugs Outcomes Research and Policies

Yiheng Liu
Yue Sun
Weiran Dai

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1366035

1,472 views

Original Research

Published on 28 May 2024

Safety assessment of tranexamic acid: real-world adverse event analysis from the FAERS database

in Drugs Outcomes Research and Policies

Ningsheng Tian
Yuxin Sun
Yingying Liu
Jie Jin
Shuai Chen
Huawei Han
Ying Zhang
Zhiwei Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1388138

2,027 views
1 citation

Opinion

Published on 24 May 2024

Overlooking the obvious: the importance of communicating safety and risks of opioids-the Israeli context

in Drugs Outcomes Research and Policies

Maram Khazen
Shelly Kamin-Friedman

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1356968

461 views
1 citation

Original Research

Published on 23 May 2024

Impact of a DSS-supported medication review on the safety of drug therapy and quality of life in patients with antithrombotic therapy

in Drugs Outcomes Research and Policies

Tanja Elnaz Hassanzadeh
Carina Hohmann
Carsten Culmsee

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1194201

1,519 views

Mini Review

Published on 22 May 2024

Improvements in technology and the expanding role of time-driven, activity-based costing to increase value in healthcare provider organizations: a literature review

in Drugs Outcomes Research and Policies

Ana Paula Beck Da Silva Etges
Porter Jones
Harry Liu
Xiaoran Zhang
Derek Haas

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1345842

1,071 views

Original Research

Published on 22 May 2024

Is it possible to diagnose therapeutic adherence in mild cognitive impairment and dementia patients in clinical practice?

in Drugs Outcomes Research and Policies

Pilar Barnestein-Fonseca
Gloria Guerrero-Pertiñez
Jose Gúzman-Parra
Esperanza Valera-Moreno
Fermín Mayoral-Cleries

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1362168

878 views

Original Research

Published on 15 May 2024

Cost-effectiveness analysis of tislelizumab plus chemotherapy as the first-line treatment for advanced or metastatic esophageal squamous cell carcinoma in China

in Drugs Outcomes Research and Policies

Yanhong Liu
Rong Shao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1225076

842 views

Original Research

Published on 15 May 2024

Time trends and regional variations in prices of anticancer medicines in China

in Drugs Outcomes Research and Policies

Jinwei Zhang
Shuchen Hu
Xingyu Liu
Xiaoyong Liu
Jieqiong Zhang
Caijun Yang
Yu Fang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1397784

628 views

Systematic Review

Published on 13 May 2024

Effect of ezetimibe–statin combination therapy vs. statin monotherapy on coronary atheroma phenotype and lumen stenosis in patients with coronary artery disease: a meta-analysis and trial sequential analysis

in Drugs Outcomes Research and Policies

Yun-Jing Zhang
Min Xu
Ji-Qiang Duan
De-Jin Wang
Shi-Liang Han

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1343582

1,140 views
1 citation

Original Research

Published on 10 May 2024

Are Turkish pharmaceutical pricing strategies an access barrier to oncology medicines for Türkiye?

in Drugs Outcomes Research and Policies

Elif Hilal Vural
Tolga Kaskati
İsmail Mert Vural
Mustafa Asım Özalp
Bülent Gümüşel

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1364341

1,752 views
1 citation

Navigation group

Articles

Corrigendum: Effectiveness of perindopril/amlodipine fixed-dose combination in the treatment of hypertension: a systematic review

The impact of Chinese volume-based procurement on pharmaceutical market concentration

Adverse events in different administration routes of semaglutide: a pharmacovigilance study based on the FDA adverse event reporting system

Analysis and discussion on the pharmaceutical centralized procurement implementation — a case study of a large provincial hospital in China

Osteogenic mechanism of chlorogenic acid and its application in clinical practice

Pharmaceutical interventions for drug-related problems in the neonatal intensive care unit: incidence, types, and acceptability

Effect of sacubitril–valsartan on left ventricular remodeling in patients with acute myocardial infarction after primary percutaneous coronary intervention: a systematic review and meta-analysis

Safety assessment of tranexamic acid: real-world adverse event analysis from the FAERS database

Overlooking the obvious: the importance of communicating safety and risks of opioids-the Israeli context

Impact of a DSS-supported medication review on the safety of drug therapy and quality of life in patients with antithrombotic therapy

Improvements in technology and the expanding role of time-driven, activity-based costing to increase value in healthcare provider organizations: a literature review

Is it possible to diagnose therapeutic adherence in mild cognitive impairment and dementia patients in clinical practice?

Cost-effectiveness analysis of tislelizumab plus chemotherapy as the first-line treatment for advanced or metastatic esophageal squamous cell carcinoma in China

Time trends and regional variations in prices of anticancer medicines in China

Effect of ezetimibe–statin combination therapy vs. statin monotherapy on coronary atheroma phenotype and lumen stenosis in patients with coronary artery disease: a meta-analysis and trial sequential analysis

Are Turkish pharmaceutical pricing strategies an access barrier to oncology medicines for Türkiye?